Background: The proximity of craniopharyngiomas (CPs) to critical neurovascular structures
can lead to a host of neurologic and endocrine complications that lead to difficulty with …

Background The growing interest in the molecular and genetic alterations of
craniopharyngiomas (CPs) is embodied in recent studies revealing insights into the CP …

The recent genomic and transcriptomic characterization of human craniopharyngiomas has
provided important insights into the pathogenesis of these tumors and supports that these …

Craniopharyngiomas (CPs) are clinically aggressive tumors because of their invasive
behavior and recalcitrant tendency to recur after therapy. There are 2 types based on their …

Craniopharyngiomas are rare benign neoplasms presenting in two different types,
adamantinomatous (ACP) or papillary (PCP), which are molecularly and clinically distinct …

OBJECTIVE Craniopharyngiomas are among the most challenging of intracranial tumors to
manage because of their pattern of growth, associated morbidities, and high recurrence rate …

Craniopharyngioma (CP) is an intracranial benign tumor that behaves aggressively due to
its location, infiltration of the surrounding nervous tissue and high capacity for recurrence …

Opinion statement The integration of targeted therapy into the multimodal management of
craniopharyngiomas represents a significant advancement in the field of neuro-oncology …

Craniopharyngiomas present unique challenges in surgical management due to their
proximity to critical neurovascular structures. This systematic review investigates genetic and …

Craniopharyngioma is a rare tumor in adults. Although histologically benign, it can be locally
aggressive and may require additional therapeutic modalities to surgical resection. Analyses …